Literature DB >> 6181090

Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody.

B F Anthony, N F Concepcion, S A McGeary, J I Ward, D C Heiner, P Shapshak, R A Insel.   

Abstract

Type-specific antigen was purified from the supernatant of type III group B streptococcal cultures, tyrosylated, and bound to microtiter wells for an enzyme-linked immunosorbent assay. The immunological specificity of the antigen and the assay was shown by (i) reaction only with homologous unabsorbed rabbit sera and (ii) inhibition after incubation of human serum with homologous but not heterologous purified antigen. The assay was quantitated by relating optical density readings to absolute amounts of human immunoglobulin G bound to the microtiter wells.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6181090      PMCID： PMC272359          DOI： 10.1128/jcm.16.2.350-354.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  29 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

4.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Radioimmunoassay for measuring antibodies specific for group B streptococcal types Ia, Ib, Ic, II, and III.

Authors:  H W Wilkinson; W L Jones
Journal:  J Clin Microbiol       Date:  1976-05       Impact factor: 5.948

6.  Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.

Authors:  B F Anthony
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

7.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

8.  Quantitative determination of the human immune response to immunization with meningococcal vaccines.

Authors:  E C Gotschlich; M Rey; R Triau; K J Sparks
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.

Authors:  C J Baker; D L Kasper; C E Davis
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307
View more
  9 in total

1.  A human IgG 3 is opsonic in vitro against type III group B streptococci.

Authors:  J S Kim; K S Kim; C A Wass; J A Short; D C Heiner
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

2.  Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults.

Authors:  W M McDonnell; J R Gilsdorf; J B Kent; J N Sheagren
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

3.  Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.

Authors:  B F Anthony; N F Concepcion; C A Wass; D C Heiner
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

4.  Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C.

Authors:  O A Akinwolere; D S Kumararatne; R Bartlett; D M Goodall; D Catty
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

5.  Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid.

Authors:  R G Bredius; P C Driedijk; M F Schouten; R S Weening; T A Out
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.

Authors:  N P Steele; R S Munson; D M Granoff; J E Cummins; R P Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B.

Authors:  A H Lucas
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

9.  Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.

Authors:  G Mancuso; F Tomasello; C von Hunolstein; G Orefici; G Teti
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.